Session 3: Biomarkers and prognostic profiling

Back

Session 3: Biomarkers and prognostic profiling

Lessons from molecular subtyping:
Professor Carlos Caldas

Clinical utility of molecular profiles:
Professor Rob Stein

Identifying who needs extended adjuvant ET:
Dr Daniel Hayes

Mutation-directed therapy:
Professor Fabrice Andre